Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Regulatory News & FDA Approvals » FDA Issues New Guidance on SARS-CoV-2 Variants for Test Developers

FDA Issues New Guidance on SARS-CoV-2 Variants for Test Developers

Feb 22, 2021
|
staff reporter

NEW YORK – The US Food and Drug Administration on Monday issued new guidance for SARS-CoV-2 test developers to evaluate the potential impact of viral mutations on the tests.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Letter Urges New Inquiry

In a letter, about two dozen researchers criticize the World Health Organization investigation into the origins of SARS-CoV-2 and call for a new inquiry, the Wall Street Journal reports.

Great Apes Get Shots, Too

National Geographic reports that nine great apes at the San Diego Zoo have been vaccinated against SARS-CoV-2.

Woodcock on Vaccines, More

Janet Woodcock, the acting commissioner of the US Food and Drug Administration, speaks with NPR about SARS-CoV-2 testing and vaccines in the US.

Science Paper Examines Molecular Contributors to Kidney Fibrosis

In Science this week: genetic study of kidney fibrosis implicates the SOX9-NAV3-YAP1 axis.

What's Popular?

In Regulatory News & FDA Approvals

  1. Cue Health Over-the-Counter COVID-19 Test Gets FDA Emergency Use Authorization

  2. Abbott Gets FDA EUA for Test That Detects Coronavirus, Three Other Respiratory Infections

  3. FDA Issues EUA to Adaptive Biotechnologies Test for T-Cell Response to COVID-19

  4. Luminex Obtains FDA Emergency Use Authorization for Expanded Respiratory Panel With SARS-CoV-2

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.